SOXX iShares Semiconductor ETF

Expense Ratio
0.34%
Dividend
0.49%
Previous close
$339.61
Est. 12 months change
+18.23%
Projected Price
$401.52

Profitability Metrics

Return on Equity (ROE)
33.93%
Return on Assets (ROA)
13.99%
Return on Invested Capital (ROIC)
34.67%
Weighted Average Cost of Capital (WACC)
12.57%
ROIC - WACC
22.10%
Updated : 2026-04-04 05:23 ET

Valuation Metrics

P/E Ratio
39.22
Forward P/E
18.71
PEG Ratio
1.37
Debt Current Ratio
3.03

Growth & Cash Flow

Gross Margin
57.26%
Operating Margin
30.64%
FCF Margin
26.75%
TTM Revenue Growth
38.86%
Projected 12M EPS Growth
109.62%

Price Change

Price % from 50 SMA
-1.31%
Price % from 200 SMA
16.25%
6 Months
20.56%
1 Year
79.23%
2 Years
51.09%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NVDA8.32%
AVGO8.29%
MU7.63%
AMD6.62%
AMAT5.94%
MRVL5.11%
KLAC4.17%
INTC4.16%
TER4.07%
MPWR4.06%

ETF Analysis

Fund Overview

iShares Semiconductor ETF (SOXX) currently reports 29 stock positions (subject to change), placing it in the conviction-weighted range by holdings breadth. The top line-up is NVDA (8.32%), AVGO (8.29%), MU (7.63%), with NVDA as the largest single weight at 8.32%. Together, the top three holdings account for 24.24%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.

Profitability & Capital Efficiency

On the question of capital productivity, ROIC is 34.67%, WACC is 12.57%, and the economic spread is 22.10%. On balance, the economic spread is positive and meaningful, suggesting the underlying holdings are building rather than eroding intrinsic value. Supporting metrics show ROE at 33.93% and ROA at 13.99%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

On a multiple basis, the portfolio trades at trailing P/E of 39.22, forward P/E of 18.71, PEG of 1.37. The trailing-to-forward compression is notable, pointing to an earnings growth narrative that, if delivered, would make current valuations more defensible. The PEG reading here is low enough to suggest investors are not being asked to overpay for the growth embedded in analyst estimates. The portfolio's holdings carry a current ratio of 3.03, pointing to strong short-term financial health. The valuation setup is broadly consistent with a market that is pricing growth without being reckless about it — a balanced but not cautious stance.

Margins & Cash Generation

The margin stack reads as follows: gross margin sits at 57.26%, operating margin at 30.64%, and free cash flow margin at 26.75%. The gross margin reading points to holdings with solid but not outsized pricing power relative to direct costs. At this level, operating margins reflect businesses with genuine scalability and above-average cost control. The portfolio's FCF margin is a standout — reflecting businesses where accounting profits translate cleanly into real cash generation. The margin profile across gross, operating, and free cash flow levels is consistently strong — a rare combination that typically indicates durable business quality.

Growth & Forward Outlook

The forward view combines two signals: the estimated 12-month price change of 18.41%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 38.86% suggesting the portfolio's businesses are collectively capturing meaningful market share or pricing power. The projected 12-month EPS growth rate of 109.6% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Putting all the pieces together, the fundamental picture is one of the more convincing setups in these metrics — strong capital returns, reasonable pricing, and a healthy forward outlook.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.